Briefing: Endless Pandemic vs. Ending It: Latest Data, Policy Options
Rethink Trade
[{'start': '136.736', 'end': '138.605', 'text': ">> GOOD MORNING EVERYONE, GOOD  AFTERNOON AND THANK YOU FOR  JOINING US TODAY.  WE HAVE A BRIEFING ON THE  ENDLESS PANDEMIC VERSUS ENDING  THE PANDEMIC AND WE WILL BE  HEARING OVER THE NEXT HOUR FROM  POLICY EXPERTS AND POLICYMAKERS  ABOUT THE LATEST DATA, ABOUT THE  CURRENT COVID SITUATION AND  POLICY OPTIONS TO END THE  PANDEMIC.  WE ARE GOING TO BE JOINED BY A  TERRIFIC LINEUP OF EXPERTS AND  AT THE END WE WILL OPEN UP AFTER  A HALF-HOUR BRIEFING FOR YOUR  QUESTIONS AND COMMENTS AND WE  ARE LIVE STREAMING ACROSS A  VARIETY OF PLATFORMS.  IF WE COULD PLEASE SILENCE  WHATEVER THE BACKGROUND NOISE IS  THERE.  DURING THE NEXT HOUR WE WILL  HEAR ABOUT HOW WE CAN AND THE  PANDEMIC AND THAT IS GOING TO  REQUIRE ENORMOUS SCALE UP OF  VACCINES, TESTS AND TREATMENTS.  ALL OF THE SPEAKERS THE QUESTION  IS THE PATHWAY SO WE WILL HEAR  ABOUT VARIOUS OPTIONS.  ALL OF THE SPEAKERS AGREED THE  ONE OPTION THAT IS -- IS TO NOT  ACT.  IT'S NOT AN INEVITABLE FUTURE  THAT WE FACE AND INEVITABLE  CYCLE OF MUTATION IN VARIANTS  THE NEXT ONE OF WHICH COULD BE  MORE LETHAL.  AS WE SAW WITH OMICRON VARIOUS  INFECTIONS CAN LEAD TO LONG  COVID, CAN REINFECT PEOPLE WHO  PARTY HAD ANOTHER VARIANT AND IT  IS NOT AN ELIGIBLE ONE.  MARCH 11 IS THE TWO-YEAR  ANNIVERSARY OF THE WORLD HEALTH  ORGANIZATION DECLARING A  PANDEMIC.  ALMOST 1 MILLION AMERICANS AND  GLOBALLY MORE THAN 5 MILLION  CONFIRMED MINIMALLY THAT'S AN  UNDERCOUNT HAVE DIED.  THE DATA IS PERHAPS 20 MILLION  THAT DOESN'T SPEAK TO THE SOCIAL  AND ECONOMIC DESTRUCTION AND THE  LASTING EFFECTS OF LONG COVID.  THE UNIMAGINABLE THERE STILL IS  NO PLAN TO END THE PANDEMIC.  NOT TO END CORONAVIRUS AND THE  PANDEMIC, IT REQUIRES ACTION IN  THE U.S. PLAYS A KEY ROLE AND  THAT'S WHY WE ARE HONORED TODAY  TO HAVE SEVERAL LEADING  POLICYMAKERS JOINING US AS WELL  AS GLOBAL PUBLIC HEALTH EXPERTS  TO DISCUSS THE PATHWAYS, THE  PATHWAYS, THEY ARE DIFFERENT  WAYS TO GO ABOUT THIS, TO ENDING  THE PANDEMIC.  CLEARLY NOT ACTING IS NOT AN  OPTION.  WE WILL START WITH CONGRESSWOMAN  JAN SCHAKOWSKY WHOSE AGE  CONGRESS 60 TO STOP THE PANDEMIC  NOW RESOLUTION TAKES THE  APPROACH TO DO ALL THE THINGS  THE REVOLUTION THAT LAYS OUT  DIFFERENT PATHWAYS TO ENDING THE  PANDEMIC AND WE WILL START WITH  HER EXPERTS DEBUNKING SOME OF  THOSE MYTHS SO WITHOUT FURTHER  ADO I WOULD LIKE TO INTRODUCE  CONGRESSWOMAN JAN SCHAKOWSKY.  SHE'S THE CHIEF DEPUTY WHIP THE  SUBCOMMITTEE CHAIRWOMAN OF THE  HEALTH AND CONSUMER SUBCOMMITTEE  OF THE ENERGY AND COMMERCE  COMMITTEE.  SHE REPRESENTS ILLINOIS NINTH  DISTRICT AND IS A LONG-STANDING  CHAMPION FOR OUR PUBLIC HEALTH  AND WORKING PEOPLE WORLDWIDE.  CONGRESSWOMAN SCHAKOWSKY.  >> THANK YOU SO MUCH AND THANK  YOU FOR YOUR INCREDIBLE  LEADERSHIP THAT I WANT TO SAY  GOOD AFTERNOON TO EVERYONE AND I  THANK ALL OF YOU WHO ARE  ATTENDING AND I ESPECIALLY WANT  TO THANK THE INCREDIBLE PANEL OF  EXPERTS.  THESE ARE REALLY WORLD-RENOWNED  PEOPLE WHO ARE HERE WHO HAVE  BEEN WORKING SO HARD ON THIS  ISSUE FOR THIS LOCAL EFFORT TO  STOP THE PANDEMIC AND I BELIEVE  THAT THIS REALLY STARTS WITH THE  TRIPS WAIVER IN MAKING THIS THIS  HAPPEN AS SOON AS POSSIBLE.  I KNOW THAT MANY OF YOU HAVE  BEEN ADVOCATES FOR THIS VERY  LONG TIME.  THE UNITED STATES GOVERNMENT CAN  PLAY A REALLY IMPORTANT ROLE AND  INDISPENSABLE ROLE, A LEADERSHIP  ROLE IN WORKING WITH SOUTH  AFRICA AND OTHER NATIONS TOO  QUICKLY AND FINALLY GET THE  WORLD TRADE ORGANIZATION WAIVER  AND FINALLY OVERCOME THE  OPPOSITION THAT IS NOW BLOCKING  THE 130 NATIONS OF THE WORLD.  THE MAJORITY OF COUNTRIES IN THE  WORLD WHO WANT THIS.  THE UNITED STATES GOVERNMENT  MUST LEVERAGE THE MASSIVE TAX  DOLLARS THAT WE ARE ALL SPENDING  TO HELP DEVELOP THESE VACCINES,  TO HELP DEVELOP THE  INTERVENTIONS AND TO USE THAT IN  ORDER TO GET THE WAIVER PASSED.  YOU KNOW I FEEL LIKE WE ARE OVER  THAT AND WE WANT TO SEE EVEN  THOUGH THE UNITED STATES HAS  DECLARED SUPPORT OF THE TRIPS  WAIVER WE NEED TO DO MORE AND WE  COULD LAUNCH AND HELP FUND LOCAL  MANDATES TO INCREASE, INCREASE  TO INCREASE THE WORK THAT WE ARE  DOING.  BY HELPING TO CREATE REGIONAL  HUBS AROUND THE GLOBE.  THERE ARE PLENTY OF COUNTRIES  THAT HAVE THE CAPACITY AND  PRODUCE A BILLION MORE DOSES OF  VACCINES.  THE UNITED STATES GOVERNMENT HAS  THE OBLIGATION TO ALL THE PEOPLE  IN THE WORLD AND TO OURSELVES.  YOU KNOW WE HAVE SAID OVER AND  OVER AGAIN THAT WHEN THE VIRUS  EXISTS ANYWHERE WE ARE IN DANGER  EVERYWHERE AND IT IS TIME FOR US  TO GET TO WORK.  WE HAVE THE TOOLS THAT WE COULD  USE AND WE OUGHT TO PUT THEM TO  WORK IMMEDIATELY.  AND I SHOULD NOTE AS LORI  MENTIONED THAT WE HAVE THIS  RESOLUTION.  WE COULD USE YOUR HELP TO GET  MORE MEMBERS OF CONGRESS TO  CO-SPONSOR THE RESOLUTION THAT  WOULD ADDRESS ALL THE ISSUES AND  ALLOW US TO GET VACCINES AROUND  THE WORLD INCLUDING TO GET  SUPPORT FOR THE TRIPS WAIVER.  SO YOU KNOW I THINK THAT THE  TIME HAS CERTAINLY COME.  WE HAVE SEEN THESE VARIANTS  DEVELOP.  NOW WE HAVE HEARD THAT THERE IS  A STEALTH OMICRON AND THE FEAR  OF COURSE IS THAT THERE WOULD BE  A VARIANT THAT WOULD BE  RESISTANT TO ALL OF THE VACCINES  THAT WE HAVE RIGHT NOW SO WE  NEED TO NOT FEEL THAT WE ARE,  AND NOT TO OVERPLAY THE DOWNTURN  NOW IN THE NUMBERS OF PEOPLE WHO  ARE GETTING SICK FROM THESE  VARIANTS AND WE NEED TO GET TO  WORK SO I JUST WANT TO THANK ALL  OF YOU FOR YOUR ADVOCACY, FOR  YOUR EXPERTISE AND FOR HELPING  US MOVE AHEAD.  I KNOW THIS HAS BEEN A LONG-HAUL  FLIGHT.  I BELIEVE IF WE CONTINUE TO DO  WHAT WE HAVE TO DO WEEKEND WHEN  SO THANK YOU VERY, VERY MUCH.  APPRECIATE YOU.  >> THANK YOU VERY MUCH  CONGRESSWOMAN SCHAKOWSKY AND TO  SET THE SCENE OF WHAT THE  CHALLENGE IS AND TO DEBUNK SOME  OF THESE MYTHS THAT SOMEHOW JUST  BY NATURE WE WILL TURN THE  CORNER AND THIS IS GOING TO GO  AWAY WITHOUT HEIGHTENED  GOVERNMENT ACTION I'D LIKE TO  INTRODUCE RITA KREYNIN A POLICY  OFFICER AT DOCTORS WITHOUT  BORDERS MEDICINE FRONTIERS U.S.  AND SHE HAS WITH HER COLLEAGUES  AROUND THE WORLD AND NSF ON THE  GROUND PROVIDING SERVICES A VERY  GOOD PERSPECTIVE ON WHAT  ACTUALLY IS HAPPENING ON THE  GROUND VIS-À-VIS VARIANT RISK  AND AXIS NOT JUST A VACCINES.  TWO TESTS AND TREATMENTS.  >> FIRST OFF LET ME THANK THE  TRADE IN THE -- IT'S A PLEASURE  TO BE HERE ALONGSIDE  REPRESENTATIVE SCHAKOWSKY AND  DeLAURO AS WELL AS PARTNER  ALLIES.  I WORK WITH DOCTORS WITHOUT  BORDERS MSF INTERNATIONAL  ORGANIZATION THAT DELIVERS  MEDICAL CARE TO PEOPLE IN CRISIS  TO MORE THAN 30 COUNTRIES  GLOBALLY.  AROUND THE WORLD THEIR TEAMS  HAVE BEEN CARING FOR COVID-19  PATIENCE TREATMENT CENTERS AND  HOSPITALS OFFERING HEALTH  EDUCATION AS WELL AS SUPPORTING  RESPONSE EFFORTS BY LOCAL  AUTHORITIES.  LAST YEAR MSS MAINTAINED  COVID-19 ACTIVITIES IN 165  PROJECTS AND 52 COUNTRIES.  EVERYTHING NSF DOES IS  PROFOUNDLY AFFECT THAT BY THE  PANDEMIC WHETHER IT'S DIRECTLY  RELATED TO COVID-19 OR NOT.  EVERY HEALTH CARE WORKER THAT  SPENDS TIME MANAGING COVID IS  LIMITED IN THE OTHER KINDS OF  CARE THEY CAN PROVIDE IN THIS IS  IN COMMUNITIES THAT HAVE LITTLE  ACCESS TO CARE.  THIS MEANS FEWER EMERGENCY  SURGERIES, FEWER TRAUMA CARE FOR  PEOPLE CAUGHT IN TRAUMA AND  FEWER CHILDHOOD VACCINATIONS.  IN ADDITION TO LONG HOURS AND  OVER WOUND HEALTH CENTERS IN  HOTSPOTS LIKE WERE STILL IN  INDIA ARE TEAMS HAVE BEEN FORCED  TO TRY TO TREAT PATIENTS AND  PREVENT -- WITHOUT ADEQUATE  SUPPLIES TO COVID-19 TREATMENTS  TREATMENTS AND TESTS.  TODAY FEWER THAN 11% OF PEOPLE  IN LOW-INCOME COUNTRIES HAVE  RECEIVED A SINGLE VACCINE DOSE.  THE COVAX FACILITY A PROCUREMENT  MECHANISM IS ABLE TO DELIVER  EQUITABLE ACCESS TO COVID-19  VACCINES TO LOW AND  MIDDLE-INCOME COUNTRIES.  COLFAX HAS FAILED TO DELIVER ON  ITS VISION.  OF THE 2 BILLION DOSES PLEDGED  IN 2021 COVAX DELIVERED ONLY  910 MILLION.  AS A RESULT ONLY FIVE AFRICAN  COUNTRIES REACHED THE WORLD  HEALTH ORGANIZATION'S 2021  YEAR-END TARGET OF FULLY  VACCINATING 40% OF THEIR  POPULATIONS.  LAST SEPTEMBER PRESIDENT BIDEN  PLEDGED THE UNITED NATIONS 70%  GLOBAL VACCINATION GOAL BY THIS  SEPTEMBER HOWEVER THERE IS YET  TO BE A PLAN PUT FORTH TO MAKE  ENOUGH DOSES TO REACH SUCH A  TARGET.  LOW VACCINATION RATES IN ONE  PART OF THE WORLD IS A PROBABLE  SCENARIO THAT THE VIRUS WILL  TAKE TWO NEW VARIANTS OF  CONCERN.  WE EXPERIENCE THIS WITH DELTA  AND ARE NOW IN THE FOURTH WAVE  OF OMICRON.  JUST YESTERDAY THE W.H.O.  ANNOUNCED A NEW OMICRON VARIANT  VERSION SLIGHTLY MORE  TRANSMISSIBLE THAN THE RETURN OF  OMICRON.  SINCE THE START OF THE PANDEMIC  IN SF AND CIVIL SOCIETY ALLIES  HAVE REPEATEDLY SAID NO ONE IS  SAFE UNTIL EVERYONE IS SAFE.  WHEN WE MET THEN AND STILL  BELIEVE TODAY BACK SCENES MUST  BE AVAILABLE TO ALL.  ADDITIONALLY OF SUPPLIES NOT  ONLY LEAD TO -- THE FDA'S RECENT  EMERGENCY USE AUTHORIZATION OF  PFIZER'S PAXLOVID THE FIRST  ANTI-VIRAL TO TREAT COVID IS  REMARKABLE ADVANCEMENT IN  COMBATING DISEASE PROGRESSION  GET THE TREATMENT CAN ONLY BE A  GAME-CHANGER OF SUPPLY MEETS  GLOBAL DEMAND.  AS WITH VACCINES HIGH INCOME  COUNTRIES ADVANCE THROUGH AT  LEAST THE FIRST HALF OF 2022.  THE VACCINATION RATES LACKING  GLOBALLY WORLD TREATMENTS CAN  EASE THE BURDEN ON OVERWHELMED  HOSPITALS WITH ONLY INCREASE IN  SUPPLY AND LOW TO MIDDLE INCOME  COUNTRIES ARE ALLOWED TO SUPPORT  GENERICS.  AFFECTING USE OF TREATMENTS  REQUIRES ACCESS TO COVID TEST  WHICH REMAINS SPARSE, SCARES  PICS USE ME MANY PLACES FOR THE  DAILY TESTING RATE AND HIGH-END  COUNTRIES AS PER-CAPITA NEARLY  10 TIMES HIGHER THAN THAT OF  MIDDLE INCOME COUNTRIES AND  CLOSE TO 100 TIMES HIGHER THAN  THAT OF LOW-INCOME COUNTRIES.  FOR THE W.H.O. 85% OF COVID-19  INFECTIONS ARE GOING UNDETECTED  IN AFRICA.  FOR EXAMPLE IN KENYA NEARLY FOUR  OUT OF 10 PEOPLE LIVE ON LESS  THAN $2 PER DAY WHILE THE  AVERAGE COVID TEST COST $11.  IF WE WANT TO STOP THE SPREAD OF  COVID WE NEED TO MAKE IT EASIER  AND CHEAPER FOR PEOPLE  EVERYWHERE TO ACCESS TASKS.  FINALLY I WILL SAY THE PUBLIC  HEALTH HUMAN RIGHTS AND ECONOMIC  FALLOUT FROM THE PANDEMIC HAVE  BEEN GRAND.  GLOBALLY 5.5 MILLION PEOPLE HAVE  DIED IN NEARLY 900,000 IN THE  U.S..  HIGH INCOME AS WELL AS LOW AND  MIDDLE INCOME COUNTRIES ALIKE  EXPERIENCED MASSIVE JOB LOSSES  AND ECONOMIC CONTRACTION  FOLLOWING INVESTMENTS AND  EXPORTS AS WELL AS A DECLINE IN  TOURISM.  THEREFORE IT'S IMPERATIVE WE  SUPPLY AN EQUITABLE ACCESS TO  COVID-19 VACCINES TREATMENTS AND  TESTS TO BREAK THE CYCLE OF  INFECTIONS AND VARIANTS.  >> THANKS LORI.  >> THANK YOU VERY MUCH FOR  PAINTING THAT VERY VIVID PICTURE  THAT MAKES CLEAR THAT WE HAVE  DIRE SHORTAGES IN THE SUPPLY,  11% UNDERSCORE TWO PEOPLE IN  DEVELOPING COUNTRIES AND NOW OF  TREATMENTS GIVEN ALL THOSE FOLKS  WILL GET INFECTED UNTIL THEY GET  VACCINES AND ALSO RAPID TESTS.  WE HEAR FREQUENTLY WELL, WHAT  CAN WE DO ABOUT THAT?  OUR NEXT SPEAKER ACHAL PRABHALA  HAS DONE AN AMAZING STUDY WITH  DOCTORS WITHOUT BORDERS AND  HUMAN RIGHTS WATCH WHERE HE  SURVEYS THE AVAILABLE QUALIFIED  FACILITIES IN THE DEVELOPING  WORLD WHERE MORE OF THE BEST  VACCINES IS IN THE MRNA VACCINES  AS WE WE'LL HEAR FROM A LOT OF  OUR SPEAKERS AT DIFFERENCE IN  QUALITY COUNTS SO IT IS MY HONOR  TO INTRODUCE ACHAL PRABHALA AND  YOU PROBABLY READ A LOT OF HIS  WRITING IN THE LAST YEARS.  HE'S COMING TO US FROM INDIA TO  SHARE THAT RESEARCH AND TO  DEBUNK THIS MYTH THAT IN THE  FACE OF THAT DIRE SHORTAGE  THERE'S NOTHING TO BE DONE.  BALONEY.  PLEASE ACHAL.  >> THANK YOU.  VACCINES ARE SOMETHING WE HAVE  HAD TO DO WITH THE PANDEMIC.  WE HAVE MADE GOOD PROGRESS WITH  VACCINATIONS AGAINST COVID.  THERE IS ONE THING WE ABSOLUTELY  DON'T HAVE MRNA VACCINES.  NOT A SINGLE MRNA VACCINE HAS  BEEN DISPENSED IN INDIA AND  UNLESS WE ALL DO SOMETHING  TOGETHER ABOUT THIS VERY SOON  IT'S GOING TO STAY THAT WAY.  IN SOUTH AFRICAN PERSONNEL THERE  IS SOME ACCESS TO MRNA VACCINES  BUT NOT BARELY ENOUGH FOR THE  SITUATION THAT I'M IN INDIA IS A  SITUATION THAT ROUGHLY HALF THE  WORLD IS AND AT THE MOMENT AND  AT THIS STAGE WHY DOES THIS  MATTER?  THERE OTHER VACCINES.  HERE IS WHY.  FIRST MRNA VACCINES CAN BE MADE  MUCH FASTER AND THEY CAN BE  REFORMULATED MUCH FASTER THAN  ANY OTHER VACCINE.  I WORK WITH AND MRNA LAB AND ONE  OF THE BEST EXPLANATIONS I'VE  HEARD IS THAT THEY CAN BE MADE  WITH ROUTINE BIOCHEMISTRY AND  THE BODY RECOGNIZES THEM.  THIS MEANS THERE ARE A LOT OF  THINGS THAT MRNA VACCINES  DISPENSE WITH THE GROWING OF  BIOLOGICAL CELLS WHICH IS  COMPLICATED AND TIME-CONSUMING  AND IMPERFECT.  USEFUL MAYBE HIS PRE-PANDEMIC  VACCINES WERE ANALOGUES AND MRNA  VACCINES ARE DIGITAL.  HOW MUCH FASTER THEY CAN MAKE?  A LOT.  A BATCH TOOK PFIZER SEVEN DAYS  TO MAKE INNOTECH ASTROZENECA TWO  MONTHS.  HOW MUCH FASTER CAN THEY BE  FORMULATED IN THE PAST IT TOOK  MORE THAN 30 DAYS TO MAKE YOUR  REFORMULATED VACCINE AND BY  CONTRAST IT TOOK ROUGHLY FIVE  MONTHS FOR TRADITIONAL  BIOLOGICAL VACCINE TO BE MADE.  THE PROBLEM PROBLEMS WE HAVE  ENCOUNTERED RECENTLY AS OMICRON  HAS CHANGED THE VACCINE  LANDSCAPE AND REENGAGE WHAT  WORKS AND WHAT DOESN'T.  ALL EXISTING VACCINES IN TERMS  OF PROTECTION AGAINST INFECTION.  I SHOULD SAY MANY VACCINES HAVE  STOP HOSPITALIZATIONS AND DEATHS  AND DEATHS IN THE SIRLEAF BUT  THE EFFECTIVENESS OF MRNA  VACCINES AGAINST TRANSMISSION OF  OMICRON FELT THE LEASE.  IT'S ALSO WHY THE U.S. IS  GETTING A --OF THE MOMENT AND  WHY THE UK CAN GET AN  ASTROZENECA VACCINE.  THOSE WORK AS WELL.  AND WHY DOES THIS MATTER.  IN CERTAIN CASES IT'S WHITE EVEN  IN THE UNITED STATES WERE YOU  ARE, IT'S WHY IN INDIA FOR  INSTANCE A TOTAL COMBINED FOR  SCHOOL DAYS IN THE LAST FOUR  YEARS FOR MY CHILDREN.  IT MATTERS THAT THIS IS COME  DOWN AND IT MATTERS WHEN YOU  HAVE CASES REGARDLESS OF THE  MILDNESS OR THE SEVERITY OF THE  SPECIFIC VARIANT YOU ARE DEALING  WITH.  MRNA MANUFACTURES HAVE AN  OMICRON SPECIFIC VARIANT.  WHEN WE DO HAVE A  SECOND-GENERATION COVID VACCINE  ONE THAT WORKS AGAINST OMICRON  AND MORE THERE'S NO DOUBT  THERE'LL BE AN MRNA VACCINE.  MY PARENTS ARE IN THEIR 80s  AND THEY LIVE IN INDIA.  THEY DESERVE AN MRNA VACCINE AND  AN OMICRON VACCINE VERY SOON.  AS THINGS STAND THEY HAVE HALF  THE WORLD'S POPULATION WITHOUT  ACCESS EITHER TO AN MRNA BOOSTER  OR FUTURE MRNA BOOSTER AND IT  INFLAMES ME AND I'M GENERALLY  CONCERNED AND GENERALLY ANGRY.  WE NEED A LASER SHARP FOCUS ON  GETTING MRNA VACCINES TO MEET  THE DIRE WORLD AND THE SAD THING  IS IF YOU FIX THEIR PROBLEM BY  VACCINATING US WITH MRNA YOU  PREVENT THE VARIANTS.  >> ACHAL THANK YOU VERY MUCH AND  THAT IS ACTUALLY THE PERFECT  SEGUE TO SUBTWENTYONE -- BOB  GARRETT WILKINSON WHO ALONG WITH  THE MANAGING DIRECTOR AND WHAT  LOOKS LIKE HAVE THE MEDICAL  SCHOOLS OF HARVARD COLUMBIA ETC.  CO-AUTHORED A BIG PAPER THAT  ALSO LOOKS AT NOT JUST THE MRNA  VACCINES ABILITY TO BE MADE  FASTER SCALED UP FASTER AND  REPROGRAMMED TO ADAPT NEW  VARIANTS THAT THE WAY THAT MRNA  VACCINES ARE CRITICAL TO END IT,  THE VARIANT CYCLE SO PLEASE  GARRETT TAKE IT AWAY.  YOU ARE ALIVE.  >> THE QUESTION WE ASK WHEN  WRITING THE REPORT IS IN LIGHT  OF OMICRON WOULD VACCINATIONS  SERIES IS NECESSARY TO BRING THE  PANDEMIC UNDER CONTROL AND OUT  OUTLINE THAT PUTS I'M SURE  EVERYBODY REMEMBERS LAST YEAR  MANY PEOPLE WERE SAYING IF WE  JUST VACCINATE 70% OF ALL  COMMUNITY'S GLOBALLY WE WILL  STOP ALL THE VARIANTS FROM  EMERGING AND THIS NOTION WAS  PREDICATED ON THE IDEA OF  ACHIEVING HERD IMMUNITY IN WHICH  WE STOP WIDESPREAD IMMUNITY AND  THIS IS IMPORTANT BECAUSE EVERY  ACTION IS A TRANSMUTATION.  IS THE PRIMARY GOAL OF THE BIDEN  FRUSTRATION STRATEGY.  OMICRON IS UNFORTUNATELY  CHANGING THE GAME.  MOST COVID-19 VACCINES DO NOT  PREVENT OMICRON INFECTION IN THE  SHORT TERM AND ALL COVID-19  VACCINES EFFICACY HAS BEEN  SEVERELY -- SO I'M PULLING UP  SOME SLIDES HERE.  SO FOR EXAMPLE RESEARCH FROM THE  UK ESTIMATES ASTROZENECA VACCINE  IS 0% EFFICACY IN PREVENTING  INFECTION SIX MONTHS LATER  HOWEVER AN MRNA BOOSTER  SIGNIFICANTLY RESCUES THAT  EFFICACY TO BETWEEN 50 AND 60%.  ALTHOUGH WE ARE WAITING TO SEE A  MUCH FURTHER THE MRNA VACCINES  TARGET THE ANCESTRAL WUHAN  STRAIN.  THEIR TARGET VACCINES ARE BEING  RIGHT NOW WILL HAVE DATA WE  THINK IN MARCH AND WE THINK THE  OMICRON TARGETED VACCINES HAD  EFFICACY AGAINST THEIR ABILITY.  FURTHER MORE VACCINE EFFICACY IN  HOSPITAL STATION WITH COVID-19  CAUSED BY OMICRON IS DEGRADED TO  PLACE RESEARCH PROTECTION  AGAINST HOSPITALIZATION FALLS  AROUND 30%.  FORTUNATELY AN MRNA IS TO  RESCUES THIS EFFICACY TO 89% OF  MULTIPLE REPORTS COME TO THE  SAME CONCLUSION.  MRNA VACCINE BOOSTER  SIGNIFICANTLY RESCUES PROTECTION  FOR AN HOSPITALIZATION FROM  BETWEEN 80 TO 90% EVEN AFTER  THREE MONTHS.  MRNA BOOSTERS AND THE STANDARD  OF CARE IN THE U.S. AND  COUNTRIES AROUND THE WORLD AND  JUST RECENTLY THE WORLD HEALTH  ORGANIZATION UPDATED THEIR  GUIDELINES TO RECOMMEND MOST  ADULTS GET A BOOSTER 46 MONTHS  AFTER THEIR PRIMARY SERIES SO  THIS IS GREAT.  WE HAVE THE TECHNOLOGY THAT CAN  BOLSTER.  DO WE HAVE ENOUGH FOR EVERYONE?  AND HAS ABSOLUTELY NOT.  LAST YEAR REPRODUCED ONLY  3 BILLION MRNA VACCINE DOSES AND  27% THE PROGRESSION CAPACITY.  HOW MANY DOING IT?  THE ROUGH MATH IS PRETTY SIMPLE  BASED ON THE AVAILABLE DATA WE  THINK PEOPLE HAVE RECEIVED  INACTIVATED VACCINES LIKE  CHINA'S VACCINE NEED TWO DOSES  TO ACHIEVE MAXIMUM PROTECTION IN  THE SAME PROBABLY GOES FOR J&J  VACCINES TO LOOK THE NUMBER OF  VACCINES LIKELY ADMINISTERED WE  ESTIMATE WE NEED 7 BILLION MRNA  BOOSTER DOSES WHICH IS 100% OF  MODERNA AND PFIZER'S PRODUCTION  OF 2022 AND IT DID NOT MEET  PRODUCTION MUSTER FURTHERMORE  THEIR 3 BILLION PEOPLE WHO  AREN'T VACCINATED AND 709 PEOPLE  WHO HAVE JUST RECEIVED ONE DOSE.  TO COVER THIS NUMBER OF PEOPLE  WITH VACCINATIONS WOULD REQUIRE  10 BILLION DOSES SO IN TOTAL  THIS IS ABOUT 17 BILLION DOSES.  UNDERSTANDABLY LOTS OF DOSES ARE  IN THE WEST AND THE WASTE WAS  20% LAST YEAR SO ADJUSTING TO  THIS WASTE BRINGS US TO A TOTAL  MADE OF 22 BILLION DOSES.  SUBTRACTING THE PRODUCTION GETS  US TO A 15 BILLION DOSE DEFICIT  IF WE WANT TO PROVIDE THE  STANDARD OF CARE TO EVERYONE.  AS I CLOSED LET ME TURN UP MY  SLIDES HERE MULTIPLE PEOPLE AT  TOLD US DON'T SAY 15 BILLION  DOSES BECAUSE THAT WILL SCARE  PEOPLE OFF.  TWO POINTS BASED ON EXPERIENCE  AND THE LESS WE THINK IT WILL  COST NO MORE THAN $12.5 BILLION  TO BUILD THE CAPACITY CAPABLE OF  PRODUCING THIS MANY DOSES.  YEAR AND A REAL COST IS AROUND  $6 BILLION.  SECOND AT 15 BILLION DOSE.  YEAR CAPACITY WOULD NOT EVEN GET  US HAVE WHITE TO THE  ADMINISTRATION'S GOAL OF  PRODUCTION.  IF YOU LOOK THE WHITE HOUSE ON  PLAN LED BY ERIC LANDRY AND JAKE  JAKE SULLIVAN IT STAYS THE U.S.  NEEDS TO BE ABLE TO REDUCE  ENOUGH VACCINE FOR THE GLOBAL  POPULATION WITHIN 200 DAYS OF  RECOGNIZING THE THREAT.  THE TWO TO 16 TRANSLATES TO  32 BILLION DOSES.  YEAR CAPACITY.  WE KNOW THAT THE EXECUTIVE  BRANCH ARE MORE THAN CAPABLE OF  GETTING THIS DONE AND GETTING TO  5 BILLION DOSES AND WHEN WE COME  BACK AND WHEN WE COME BACK WE  WILL TALK ABOUT HOW WE DO THAT  SO BACK TO YOU.  >> THANK YOU VERY MUCH GARRETT.  FOR FOLKS WHO HAVE COME IN AND  MISSED THE BEGINNING HERE IS  WHERE WE ARE.  PEOPLE AROUND THE WORLD DON'T  HAVE VACCINES AND TREATMENTS AND  DO NOT HAVE TESTS.  TO GET THAT NUMBER UP -- THE  GOOD NEWS IS WE HAVE THE  CAPACITY TO DO THIS.  WE HAVE TO MAKE LYRICAL PUGGLE  CHOICES TO TAKE NECESSARY  ACTIONS.  22 BILLION DOSES FOR COVID AS WE  HAVE HEARD MORE BROADLY THE U.S.  PANDEMIC PREPAREDNESS PLAN NOT  JUST FOR COVID IS TO HAVE  CAPACITY TO MAKE EVEN MORE SO  THE INVESTMENTS IN GETTING THE  CAPACITY NEEDED TO END THIS  PANDEMIC IS PART OF A LONG-TERM  INVESTMENT OF BEING READY FOR  THE FUTURE WHICH THEN BEGS THE  QUESTION IN PART TO WHICH IS HOW  THE HECK DOES THAT GET DONE?  FOR FOLKS WHO ARE NOT YET  CO-SPONSORS IN OUR CONGRESSIONAL  BODIES H. CONRAD 60 STOP THE  PANDEMIC NOW RESOLUTION THAT IS  THE DO ALL RESOLUTION SO WE WILL  HEAR ABOUT ALL OF THAT THEY CAN  BE DONE BECAUSE THE ONLY OPTION  THAT IS NOT ON THE TABLE IS NOT  DOING ALL THE THINGS I'M GOING  TO GO BACK NEXT TO OPTIONAL AND  I'M GOING TO ASK OPTIONAL TO  TALK ABOUT AND IDENTIFIED A  STUDY WHICH YOU CAN SEE AND  HUMAN RIGHTS WATCH'S WEB SITE  HIS STUDY SHOWS THERE QUALIFIED  PRODUCES PRODUCERS AROUND THE  WORLD AND THAT'S A RED HERRING.  SO HOW CAN WE TRANSLATE THAT  CAPACITY INTO THE DOSES THAT ARE  NEEDED BECAUSE WE HAVE A HARSH  REALITY.  THEIR HANDFUL OF THE COMPANIES  THAT ARE THE ORIGINATORS OF THE  CURRENT MRNA VACCINES AND THEY  HAVE NOT VOLUNTARILY SHARED THAT  INFORMATION.  THEY ARE FRANKLY NOT EVEN MADE  CONTRACT MANUFACTURING AVAILABLE  SO ACHAL PLEASE PICK UP FROM IT  CAN BE DONE TO THE VISION OF HOW  IT CAN BE DONE PLEASED.  >> THANK YOU VERY MUCH.  THE REALLY BIG SEEKER WITH MRNA  VACCINES IS THAT THEY ARE EASIER  TO MAKE AND CAN BE MADE BY MORE  COMPANIES AROUND THE WORLD THAT  CAN MAKE USE OF TRADITIONAL  OLD-FASHIONED METHODS.  I UNDERSTAND THIS FLIES IN THE  FACE OF CONVENTIONAL WISDOM.  TO HELP WITH THAT MY COLLEAGUE  AND I WORKED ON THIS FOR SEVERAL  MONTHS.  I WOULD YOU TO READ IT.  I'LL PROVIDE YOU A SHORT SUMMARY  WHICH IS WHAT IS THE  CONVENTIONAL FIGURE?  MRNA TECHNOLOGY IS BRAND-NEW.  IT'S NEVER BEEN DONE AND IT'S  SUPER COMPLICATED AND THAT MEANS  THOSE WHO ARE ALREADY MAKING IT  AND HAVE THEM NEXT SUPER SPECIAL  LEAP PLANTS IN NORTH AMERICA AND  EUROPE CAN DO IT AND YES WE LOVE  TO VACCINATE THE WORLD.  THIS IS SO COMPLICATED.  BECAUSE IT LIVED IN INDIANA  PLACE THAT I GREW UP IN I  UNDERSTAND PERFECTLY WELL THERE  SIGNS THAT HAPPENS HERE AND  CONTINUES TO HIM VERY EARLY ON  IN THE PANDEMIC THAT  CONVENTIONAL WISDOM THAT YOU AND  I HEARD WAS COUNTERED BY PEOPLE  FROM MANUFACTURING IN THE  PHARMACEUTICAL INDUSTRY WHO SAID  THAT'S JUST NOT TRUE AND IT  TURNS OUT NOT ONLY IS THAT  CONVENTIONAL WISDOM WRONG BUT  THE INVERSE IS THE TRUTH AND I  WILL EXPLAIN THIS.  ONE OF THE OLDEST VACCINE  TECHNOLOGIES WE HAVE IS  SOMETHING CALLED THE INACTIVATED  VIRUS VACCINE A KILLED VIRUS  WERE YOU TAKE THE PATH AGENDA  LIFE PATHOGEN IN THE KILL IT AND  YOU MAKE A VACCINE.  THESE ARE THE TWO VACCINES FROM.  THIS IS VACCINE USED IN INDIA.  TO THEIR CREDIT THEY HAVE  VACCINATED HALF THE WORLD WITH  THEIR VACCINES AND AGAIN THE  SECRET WITH THE OLDEST VACCINES  IS THAT THEY ARE ALMOST  IMPOSSIBLE TO MAKE PRAY THEY  REQUIRE FACILITIES THAT HAVE THE  SAFETY REQUIREMENTS THAT IS SO  STRINGENT THEY REQUIRE LEVEL 3  FACILITIES AND BY EXAMPLE THE  WUHAN VIROLOGY LAB IS ONE NOTCH  ABOVE THIS.  THERE ARE SO FEW OF THESE  FACILITIES IN THE WAYS THAT WE  WOULD EXPECT PHARMACEUTICALS TO  BE MADE.  OUR NEWEST TECHNOLOGY IS NOT  SUPER COMPLICATED.  I SAY EASY AND A QUALIFIED  SENSE.  ALL VACCINES -- THERE'S NO  QUESTION THAT MRNA VACCINES ARE  MANUFACTURED VACCINES IN THE  WORLD.  THIS IS SOMETHING THAT HAS BEEN  IN EFFECT.  I'M MODERNA AND PFIZER SO -- IT  IS MADE BY A PHARMACEUTICAL  MANUFACTURE THAT ACCOMPANY CAN  MAKE VACCINES.  WE HAVE IDENTIFIED OVER 100  COMPANIES IN AFRICA THAT THEY  CAN MAKE AN MRNA VACCINE  POTENTIALLY WITH EXTREMELY  HIGH-QUALITY STANDARDS WITH  STERILE INJECTABLES OR BIOLOGIC  OR BREAST-CANCER BIOLOGIC TO YOU  IN THE UNITED STATES OR THE  EUROPEAN UNION SO THESE ARE  MANUFACTURES THAT IT MADE THINGS  THAT GO INTO YOUR ARM.  THEY ARE LOCATED ON THE AFRICAN  CONTINENT IN ASIA SEVERAL  COUNTRIES AND THEY SHARE AND  LATIN AMERICA.  THE WAY IN WHICH THEY CAN  PARTICIPATE IN THIS EXERCISE IS  TURNING YOU INTO A RICH UNCLE AS  FAR AS THE BOOSTER BECAUSE WE  CAN DO THIS OURSELVES AND I  CANNOT STRESS THIS ENOUGH HOW  WELL BEGIN DO THIS OURSELVES.  THEY ARE COMPANIES MAKING MORE  COMPLEX PRODUCTS.  WHAT IS STOPPING THEM FROM  MAKING MRNA VACCINES?  THE FACT WITH THE TECHNOLOGIES  WE HAVE THE MONOPOLIES OF  BioNTECH, PFIZER AND MODERNA.  LORI MENTIONED IT'S LESS THAN A  HANDFUL WITH SPACE TO SPARE.  WE NEED TO FIND A WAY BY WHICH  MODERNA AND BioNTECH EXTEND  THE EXACT SAME MANUFACTURING  CONTRACT OPERATIONS THAT THEY  HAVE IN NORTH AMERICA AND EUROPE  BECAUSE THEY ARE ENGAGING WITH  OTHER PRODUCERS TO MAKE THEIR  VACCINES FOR THEY JUST CAN'T  MAKE ENOUGH OF THEIR OWN VACCINE  AND WHAT WE NEED TO GET THEM TO  UNDERSTAND IS IT'S TO THEIR  BENEFIT OUR BENEFIT IN YOUR  BENEFIT AS CITIZENS OF THE  UNITED STATES TO HAVE US BE ABLE  TO VACCINATE OURSELVES WITH MRNA  VACCINES WHICH ARE NOT JUST THE  EASIEST PROCESS TO MAKE THAT  WILL SOON BECOME QUITE POSSIBLY  THE ONLY VACCINES TRULY  PROTECTING OURSELVES AGAINST  EVERY POSSIBLE METRIC IN THE  PANDEMIC NOW AND GOING FORWARD.  >> ACHAL THANK YOU VERY MUCH OF  GOING BACK TO H. CONRAD 60 AND  THERE'S THE OPTION OF HAVING THE  MANUFACTURES DO MORE CONTRACT TO  GET MANUFACTURING AROUND THE  WORLD.  ANOTHER OPTION IS PART OF THE  RESOLUTION IS TO USE EXISTING  CONGRESSIONAL AUTHORITIES THAT  EXIST, STARTED THIS -- THE  STATUTORY LIKE THE PART DEFENSE  PRODUCTION ACT TO MANDATE THE  SHARING OF THE RECIPES BY  QUALIFIED PRODUCERS.  THERE'S ALSO THE OPTION OF  MAKING MORE HERE AND I'D LIKE TO  REINTRODUCE GARRETT TO TALK  ABOUT THE OPTION OF MAKING MORE  HERE AND HOW FEASIBLE THAT IS.  MRNA WE NEED MORE OF IT IN  DIFFERENT PATHWAYS TO GET THERE  AND WE WE'LL HEAR FROM -- ABOUT  HOW THE INTELLECTUAL PROPERTY  REQUIRES TO WAVE THE LIMITS ON  INTELLECTUAL PROPERTY IN THE WTO  AGREEMENT AND WE HAVE JUST BEEN  JOINED BY THE CHAIRMAN OF THE  APPROPRIATIONS COMMITTEE IN  TRYING TO MAKE SURE THE  GOVERNMENT -- WE WILL POP HER IN  AFTER GARRETT BEFORE WE GO TO  RITA.  GARRETT, PLEASE.  >> THANKS LORI.  I WANT TO BACKUP A MOMENT TO  GIVE EVERYONE IN THE ROOM A  SENSE OF THE CONSENSUS ON A  MANUFACTURING PROBLEM.  WAY BACK IN 2020 GLOBAL HEALTH  EXPERTS AND ADVOCATES WARNED  AVOIDABLE VACCINE SCARCITY WAS  POSSIBLE.  VACCINE PRODUCERS OF ONLY VESTED  IN A LIMITED REDUCTION CAPACITY.  DOES NOT MAKE SENSE FROM A  BUSINESS PERSPECTIVE TO SPEND  MILLIONS OF DOLLARS ON CAPACITY  TO MAKE GLOBAL DEMAND  IMMEDIATELY READ THE CAN SPEND A  MINIMAL INVESTMENT IN CAPACITY  AND COLLECT EVERYONE'S MONEY  UPFRONT.  YOUR LIMITED CAPACITY  PRODUCES -- AND MORE DOSES ARE  PRODUCED IN 2021 AND  MANUFACTURING CAPACITY WAS THE  BOTTLENECK.  THE OBVIOUS SOLUTION EXPERTS  PROPOSED WAS FOR GOVERNMENTS TO  INCREASE THE NUMBER OF COVID  VACCINE LINES ESPECIALLY FOR  MRNA VACCINES AT HOME AND AROUND  THE WORLD AND RECOMMENDATIONS TO  SCALE MANUFACTURING FOR PEOPLE  LIKE ANTHONY FAUCI THE WORLD  HEALTH ORGANIZATION NUMEROUS  CURRENT AND FORMER HEADS OF  STATE OVER HALF OF THE  DEMOCRATIC CAUCUS IN THE HOUSE  OF REPRESENTATIVES INCLUDING  REPRESENTATIVE MILLER AND  SCHAKOWSKY AND HUNDREDS OF  SCIENTIFIC ORGANIZATIONS AND  UNIONS IN MILLIONS OF  INDIVIDUALS.  WE KNEW WHAT TO DO -- SCIENCE  DIDN'T LISTEN AND USED  $8 BILLION NOT TO EXPAND  MANUFACTURING CAPACITY TO  PURCHASE 1 BILLION DOSES FROM  PFIZER AND WHAT HAPPENED THERE?  THE ORDER WAS PUT ON THE BACK OF  A LONG QUEUE AND AS A RESULT THE  U.S. IS ONLY DONATED 400 MILLION  DOSES OF VACCINE JUST ONE THIRD  OF THE TARGET.  HUNDREDS OF MILLIONS OF DOSES IN  THE U.S. HAVE NOT EVEN BEEN YET.  IN THE CONTRARY DID LISTEN TO  THE EXPERTS AND THE CHINESE  GOVERNMENT BUILT CAPACITY AND  BUILD FACTORIES INCLUDING THREE  IN AFRICA AND EXPORTED  1.6 BILLION DOSES OF THEIR  VACCINES TO OTHER COUNTRIES FOR  TIMES WITH THE U.S. WAS ABLE TO  DO.  UNFORTUNATELY THE VACCINES DON'T  WORK WELL.  HOW TO CATCH UP.  WE THINK THE FASTEST WAY TO MEET  THE GLOBAL NEED IS BY PAYING AN  EXPERIENCED CONTRACTING  ORGANIZATION TO BUILD THE  FACILITY WITH ENOUGH LINES.  THE GOVERNMENT COULD -- THEY BE  OPERATED BY MANUFACTURE.  WE THINK THIS WOULD COST  $6 BILLION WOULD BE COMPLETED IN  FOUR TO SIX MONTHS FOR THIS  MODEL IS THE GOVERNMENT-OWNED  CONTRACTOR OWNER.  IT'S BEEN USED SINCE THE  MANHATTAN PROJECT TO MANUFACTURE  TECHNOLOGIES CRITICAL TO U.S.  NATIONAL SECURITY.  SO WE MAKE MUNITIONS.  WE USE IT TO HELP SEQUENCE THE  HUMAN GENOME AND A CUTTING-EDGE  NUCLEAR FUSION RESEARCH THAT WE  KNOW IT CAN MAKE MRNA VACCINES.  THEY CAN GET THIS DONE FAST SO  WHAT ARE THE ADVANTAGES?  YOU CAN TACKLE THE MANUFACTURE  MRNA VACCINES THAT UNFORTUNATE  NONE OF THE -- COULD BEGIN  PRODUCTION EVEN IF WE SHARED  SECRETS OF THEM.  IT WOULD TAKE MONTHS TO COMPLETE  TO PROVE THEIR PRODUCT WAS  EQUIVALENT TO MODERNA AND PFIZER  AND FURTHERMORE AS A SCENE WITH  ASTROZENECA IT IS NOT RESULT IN  THE SCALE OF MANUFACTURING WE  NEED.  INDIA WHICH MAKES ASTROZENECA  HAS A COMPANY LIKE PFIZER AND IS  CONSTRAINED.  FURTHERMORE THE WHITE HOUSE HAS  STAUNCHLY OPPOSED TECHNOLOGY TO  OTHER COUNTRIES.  IT'S FASTER AND CHEAPER BECAUSE  OF ECONOMIES OF SCALE.  GLOBALLY DISTRIBUTED  MANUFACTURING IS HELPFUL FOR THE  REASONS OPTION ON MY PARTNERS IN  HEALTH OF AND WORKING TO GET THE  PLATFORM TO COMPANIES IN  COUNTRIES LIKE RWANDA APPEARED  AS WE HAVE ARTICULATED IF THE  BIDEN ADMINISTRATION CHANGE HIS  MIND DECIDED TO SEE MRNA  PRODUCED IN THE GLOBAL SOUTH IS  LARGE VACCINE SHORTAGE WOULD  ONLY MAKE TECH TRANSFER MORE  POSSIBLE.  THAT'S BECAUSE HE WAS WOULD HAVE  FUNDING AND PERSONAL TRAINING TO  BUILD PRODUCTION LINES IN THE  U.S. CAN INVITE SELECT  MANUFACTURES TO BECOME PART OF  THIS PROCESS AND OPERATE THESE  LINES.  THE U.S. HAS DONE WITH THE  BIPARTISAN POPULAR FOOD PROGRAM.  I HAVE TO CLOSE BY SAYING AND I  CANNOT BE MORE SERIOUS ABOUT  THIS AND THERE'S BROAD AGREEMENT  ABOUT THIS IN THE PUBLIC HEALTH  COMMITTEE CONGRESS NEED TO  UNDERSTAND JUST SCIENCE IN THE  WHITE HOUSE WILL NOT BE ASKING  FOR ENOUGH RESOURCES TO CLOSE  THE MRNA VACCINES PROJECT TO  CONGRESS WHICH TO GET TOPLINE  NUMBER FROM THE WHITE HOUSE AND  FALLS IN LINE BEHIND THAT WE  WILL FAIL.  UNFORTUNATELY WE HAVE A WHITE  HOUSE COORDINATOR WHO -- EXPERTS  RECOMMEND FOR BRINGING THE  PANDEMIC UNDER CONTROL.  HIGH-QUALITY MASS AIR CLEANING  TECHNOLOGY INTO PUBLIC SPACES  VACCINE PRODUCTION AND MUCH  MORE.  WE CALL AN EXPERT COMMITTEE TO  INCREASE SUPPLY AND IS ONLY NOW  STARTING TO TAKE ACTION FOR  PREVENTABLE -- SO TALK TO MOST  OF THE PROCEDURES WANTED TO  COVID THEY SAY THEY ARE OUT OF  MONEY AND THE IMPACT OF PLENTY  OF MONEY.  THERE MUST BE AN EFFORT  ENCLOSING IN CONGRESS TO GET  MILLIONS OF DOLLARS TO AGENTS TO  SCALE MRNA THAT MANUFACTURING  CAPACITY AND BILLIONS OF DOLLARS  TO AGENCIES OF USA TUBE DELIVER  THOSE VACCINES IN THE ARMS FOR  THEIR POINT OF EXPERTS WHO CAN  MAKE THAT PUSH.  IF YOU FALL IN LINE WITH THE  WHITE HOUSE I PROMISE WE'LL COME  UP SHORT SO THANK YOU.  >> THANK YOU GARRETT.  CONGRESSWOMAN ROSA DeLAURO IS  AN ENORMOUS CHAMPION OF WORKING  PEOPLE AND ACCESS TO MEDICINES  AND PUBLIC HEALTH AS CHAIRWOMAN  OF THE APPROPRIATIONS COMMITTEE  SHE HAS BEEN THE PERSON WHO HAS  CREATED SO MUCH POSITIVE CHANGE  FOR OUR COUNTRY IN THE LAST YEAR  AND ALSO HAS BEEN A LEADER IN  DEALING WITH THE OVERREACH OF --  HER PARTNERSHIP WITH  CONGRESSWOMAN JAN SCHAKOWSKY HAS  LED TO SUPPORT BY THE  ADMINISTRATION OF THE WTO LIMITS  ON INTELLECTUAL PROPERTY THAT  LIMIT SUPPLY.  IT IS MY HONOR TO INTRODUCE  CONGRESSWOMAN ROSA DeLAURO  FROM CONNECTICUT'S THIRD  DISTRICT WHO WILL SPEAK BROADLY  TO ALL THE THINGS THAT NEED TO  BE DONE.  WE ARE AND THEY SHOULD MORTGAGE  SPORT.  DO NOT GO AWAY -- WE ARE ON A  SMORGASBORD.  CONGRESSMAN PLEASE.  >> THANK YOU SO MUCH LORI AND  GOOD MORNING TO EVERYONE, GETS  ITS AFTERNOON BY NOW.  I WANT TO SAY THANK YOU TO YOU  LORI FOR YOUR LEADERSHIP AND SO  MANY MORE AND VERMONT TO HER --  MODERN TODAY'S BRIEFING TODAY  WANT TO SAY THANK YOU TO THE  PANEL, THANK YOU FOR THE  WONDERFUL EFFORTS IN WHAT'S  GOING ON IN AFRICA AND WHAT CAN  BE DONE.  YOU ARE RIGHT WE NEED TO BREAK  THAT MYSTIQUE AND TALK ABOUT HOW  IT CAN BE PRODUCED.  GARRETT AND ACHAL THINK YOU TO  MY COLLEAGUES AND PARTNERS IN SO  MANY OF THESE ISSUES AND JAN  SCHAKOWSKY.  YOU'VE BEEN OUTSTANDING URGING  THE ADMINISTRATION TO SAFEGUARD  AMERICA'S HEALTH AND ECONOMIC  SECURITY AND FINALLY TO DELIVER  ON THEIR PLEDGE TO SAVE LIVES  AROUND THE WORLD BY LEADING THE  GLOBAL VACCINATION EFFORT IN THE  PANDEMIC WHICH IS WHY WE HAVE A  SIMPLE CHOICE.  AND THOSE PANDEMIC OR ENDING IT  AND WE CAN END THE PANDEMIC.  THAT REQUIRES ACTION NOW.  LAST YEAR I HELD THE LABOR HHS  SUBCOMMITTEE AND APPROPRIATIONS  AND I DID A HEARING WITH  DIRECTOR PACE ON HER NATION'S  ROLE IN THE GLOBAL COVID-19  VACCINE EFFORT.  I HELD A HEARING BECAUSE I AM  DISTURBED BY THE GENERAL OF  URGENCY IN ENSURING EVERY PERSON  ACROSS THE WORLD HAS ACCESS TO  THE COVID-19 VACCINE.  WHILE THE UNITED STATES IS A  LEADER IN THE FIGHT TO VACCINATE  THE WORLD I DON'T UNDERSTAND WHY  IS IT TAKING US ALONG TO  MANUFACTURE THE VACCINE.  FOR THE LIFE OF ME I CANNOT  UNDERSTAND WHY WE ARE STILL IN  THIS PREDICAMENT.  PEOPLE ARE DYING AND TIME IS OF  THE OFFICE -- IS OF THE ESSENCE  IN THE MIDST MODERNA IS MAKING  BILLIONS OFF THE SUFFERING OF  THOSE THEY PROPOSE TO SAVE.  LAST NOVEMBER I JOINED AS THE  LEAD CO-SPONSOR OF H. RES. 60  THE END OF PANDEMIC NOW  RESOLUTION BUT IT'S CRITICAL AND  IT CALLS FOR THE U.S. AND THE  EUROPEAN GOVERNMENTS TO UNITE TO  ENACT A WAIVER OF TRADE RELATED  ASPECTS OF INTELLECTUAL PROPERTY  RIGHTS IN THE WORLD TRADE  ORGANIZATION TRADE ORGANIZATION  TO INCREASE TAX IN PRODUCTION  AND IN THE PANDEMIC RED  PRESIDENT BIDEN ANNOUNCED THIS  AND I STRONGLY SUPPORTED HIS  DECISION TO DO SO BUT THE ONLY  WAY TO END THE PANDEMIC  SAFEGUARD AMERICANS HELP AND  ECONOMIC SECURITIES FOR THE U.S.  TO DELIVER ON THE PRESENCE  PLEDGED TO SAVE LIVES.  LEADING THE VACCINATION EFFORT.  H. RES. 16 HELPS US MOVE FORWARD  IN ACHIEVING OUT AND IN CONCERT  WITH THE PRESIDENT AND HIS  ADMINISTRATION.  WE HAVE TO DELIVER ON THE  AGREEMENT TO WAVE INTELLECTUAL  PROPERTY PARTIES THAT ARE  LIMITING SUPPLIES OF THE  TREATMENTS FOR DIAGNOSTIC TESTS  CRITICAL TO ENDING THE PANDEMIC  TO TIME AND AGAIN WE HAVE MADE  IT CLEAR THAT WHILE WE HAVE MADE  ENORMOUS STRIDES VACCINATING THE  U.S. POPULATION HERE AT HOME NO  ONE IS SAFE UNTIL EVERYONE IS  SAFE AND AS WE ALL KNOW THAT  CORONAVIRUS CONTINUES SURGING IN  FAR TOO MANY COUNTRIES AROUND  THE WORLD.  I TOO AM CONCERNED ABOUT WHAT  THE REQUEST MAY BE ON WHAT WE  WILL DO WITH REGARD TO VACCINES  AND I'M VERY CONCERNED AS YOU  POINTED OUT GARRETT THAT IT WILL  BE TOO LITTLE TO REALLY MAKE A  DIFFERENCE.  I DON'T UNDERSTAND WHY WE  HAVEN'T USED THE DEFENSE  PRODUCTION ACT AND I DON'T  UNDERSTAND WHY ALL THOSE EFFORTS  HAVE NOT BEEN USED.  IT'S EXTRAORDINARY TIMES  DEMANDING EXTRAORDINARY  MEASURES.  I CONTINUE TO SUPPORT WHAT WE  DID LAST YEAR TO TEMPORARILY  WAVE SOME OF THE WORLD'S  INTELLECTUAL PROPERTY RULES TO  INCREASE SUPPLY.  IF THERE'S ANYTHING WE CAN ALL  AGREE ON IS PEOPLE NEED TO HAVE  ACCESS.  I SAY THIS AT EVERYONE OF THESE  MEETINGS ITS IMMORTAL  RESPONSIBILITY FOR US TO DO  THAT.  THE STAKES COULD NOT BE HIGHER.  IN ACTION IS NOT AN OPTION.  HOW CAN WE SIT AROUND AND DEAL  WITH MORE, IT ALMOST ECONOMIC  HARDSHIP SOCIAL POLITICAL  DISRUPTION AROUND THE WORLD?  THAT IS WHAT UNDERLIES NOT JUST  PRODUCING A VACCINE IN GETTING  AT HERE WE NEED TO HELP WITH  DELIVERY AND WHAT ARE THE  UNDERLYING REASONS?  THAT IS WHAT NEEDS TO DRIVE THE  EFFORT.  WE WILL ONLY BE SIX TO PUT THE  WAIVER DONE.  WE HAVE TO PUT PRESSURE  COUNTRIES AND MODERNA HAS  PROVIDED $10 BILLION.  TODAY THEY'D KNOW IT'S A  SCIENTIFIC OF THE NIH LEADING  SCIENTISTS IN THIS EFFORT.  THEY WANT TO CONTROL THE  PROCESS.  WE SHOULD NEVER ALLOW THEM TO BE  ABLE TO DO THAT.  AND WHAT WE CAN'T FALL BACK ON  IS WE HAVE MADE MORE DONATIONS  IN EVERY COUNTRY IN THE WORLD.  IT'S INADEQUATE AND YOU POINTED  AT GARRETT WE HAVEN'T MADE GOOD  ON WHAT WE SAID WE WERE GOING TO  DO SO THIS IS NOT THE ANSWER TO  THE PROBLEM.  WE NEED THE WAIVER, WE NEED THE  MITE AND THE STRENGTH OF THE  DEFENSE PRODUCTION ACT AND WE  NEED WHAT I CALL NOT NUDGING THE  PHARMACEUTICAL COMPANIES.  APPLYING A HAMMER TO GET THEM TO  MOVE IN TO GET THIS DONE.  AGAIN TO ALL OF YOU -- I'M A  BELIEVER THAT YOU CONTINUE DOING  WHAT WE ARE DOING, IF WE -- IF  THEY DON'T HEAR YOU TODAY THEY  MAY HEAR YOU TOMORROW THE DAY  AFTER, THE DAY AFTER AND THE DAY  AFTER.  SO I APPLAUD YOU FOR WHAT YOU  ARE DOING TODAY IN HELPING  EXPAND THE SUPPLY OF VACCINE  GETTING THEM DELIVERED WORKING  WITH THEIR INTERNATIONAL  PARTNERS AND CONGRESS.  THIS IS ONE OF THE MORAL  QUESTIONS OF OUR TIME AND WE  NEED TO BE ON THE RIGHT SIDE.  WHAT THAT MEANS TO ME IS  PRIORITIZING PEOPLE OVER  PHARMACEUTICAL PROFITS IN  ENSURING THE VACCINE IS DOING  OUR PART.  IF YOU THINK ABOUT IT IN TERMS  OF A PRAGMATIC OR POLITICAL  TERMS THE UNITED STATES SHOULD  BE THE LEADER AND EXERCISE THAT  LEADERSHIP ROLE AROUND THE WORLD  I THINK THAT HELPS TO RESTORE  HER ONCE VERY IMPORTANT VIEW OF  THE REST OF THE WORLD DOES THE  UNITED STATES LEADS ON EVERY  FRONT AND ON THIS ONE WE NEED TO  GET IT DONE AND WE NEED TO  APPROPRIATE THE DOLLARS AND WE  NEED TO APPROPRIATE THE DOLLARS  TO MAKE THIS HAPPEN.  IT IS ABOUT SAVING LIVES AND  THEIR IS NO MORE NOBLE GOAL AND  I THANK YOU FOR WHAT YOU ARE ALL  DOING IN TERMS OF ACHIEVING THAT  GOAL.  THANK YOU VERY MUCH LORI AND  EVERYONE.  I APPRECIATE IT AND WE ARE IN  THE MIDST OF APPROPRIATIONS  NEGOTIATIONS IN DEALING WITH THE  COMPETE ACT ON THE FLOOR OF THE  HOUSE WHICH I NEED TO SPEAK ON  SO THANK YOU VERY MUCH.  >> THANK YOU VERY VERY MUCH  CONGRESSWOMAN DeLAURO FOR YOUR  INSPIRED LEADERSHIP AND WENT TO  THE FLOOR AND SAVE US.  A VERY IMPORTANT PART OF THIS  EFFORT IS YOUR LEADERSHIP SO  THANK YOU SO MUCH FOR FINDING  THE TIME TO JOIN US AND I'M  GOING TO REINTRODUCE RITA  BECAUSE WHAT WE HAVE HEARD IS  WHETHER OR NOT WE ARE GOING TO  MAKE MORE IN THE U.S. WE ARE  GOING TO MAKE MORE AROUND THE  WORLD AND I WOULD SAY WE NEED TO  DO BOTH, IF YOU NEED TO HAVE  ACCESS TO THE TECHNOLOGY AND  WHAT THE CONGRESSWOMAN ASKED IS  WHY THE IS THIS HAPPENING AND I  WILL ANSWER MONOPOLY, AND  MONOPOLY, MONOPOLY WHILE  ANSWERING QUESTIONS THAT HAVE  BEEN ASKED BY CONGRESSIONAL  STAFF WILL THIS BE AVAILABLE IN  THE ANSWER IS YES.  THERE'S A GROUP DOING  ANTIMONOPOLY POLICY ON OUR WEB  SITE AE LP SO THIS WILL BE  AVAILABLE.  HOW DO WE BREAK THOSE MONOPOLIES  IN ONE OF THOSE THINGS IS  OBVIOUSLY GETTING THE  INTELLECTUAL PROPERTY TEMPORARY  WAIVER OF THE WTO SARITA CAN YOU  UPDATE OF SOME OF WHAT IS GOING  ON THERE AND WHAT NEEDS TO BE  DONE BECAUSE AGAIN THE ONLY  OPTION IS WHAT WE CANNOT DO IS  TO DO NOTHING AND WE CAN ALL  THANK RITA.  >> I WILL START OFF BY SAYING  INTELLECTUAL PROPERTY BARRIERS  IN PANDEMIC SHOULD NOT MIX AND  AS THEY STAND IP PROTECTIONS  ALLOW A COMPANY THE RIGHT TO  CONTROL MANUFACTURES OF THE  MEDICAL PRODUCT AND EXCLUDE  OTHER COMPANIES AND GOVERNMENTS  FROM DOING SO WHICH RESULTS IN  LESS MARKET COMPETITION REDUCE  GLOBAL SUPPLY AND PRICE-GOUGING  SO IN OCTOBER OF 2020 SOUTH  AFRICA AND INDIA REPORTED A  PROPOSAL AT THE WORLD TRADE  ORGANIZATION TO WAVE  INTELLECTUAL PROPERTY PAIRS OF  COVID-19 MEDICAL TOOLS FOR THE  DURATION OF THE PANDEMIC FOR THE  TRIPS WAIVER WOULD ALLOW  ADDITIONAL MANUFACTURES TO ALLOW  MORE COVID-19 MEDICAL TOOLS AND  HELP BOOST GLOBAL SUPPLY FASTER.  WHILE PRESIDENT BIDEN MADE THE  DECISION TO SUPPORT THE WAIVER  LAST MAY WE NEED THE U.S.  VIS-À-VIS THE UNITED STATES  TRADE REPRESENTATIVE TO LEAD THE  INTERNATIONAL COMMUNITY WITH THE  ADOPTION OF THE WAIVER.  THIS CAN'T JUST BE FOR CERTAIN  PRODUCTS FOR THE WTO MUST WAVE  INTELLECTUAL PROPERTY BARRIERS  NOT ONLY ON COVID COVID-19  VACCINES.  AS WELL AS MEDICINES AND  DIAGNOSTICS AND THEIR UNDERLYING  TECHNOLOGIES RAW MATERIALS AND  OTHER ELEMENTS NEEDED FOR  ADDITIONAL MANUFACTURING TO  SCALE UP GLOBAL SUPPLY.  LIMITING THE SCOPE IN THE IP THE  PRODUCTS AND GEOGRAPHY WILL NOT  SOLVE THE PROBLEM WE ARE FACING  IN VARIANTS WILL TRANSCEND  BORDERS SO WHERE ARE WE IN THE  PROCESS?  THE CONFERENCE SCHEDULED FOR  NOVEMBER 2021 FOR THE FATE OF  THE WAIVER WAS TO BE DECIDED WAS  POSTPONED DUE TO OMICRON.  WHILE SMALL GROUP NEGOTIATIONS  CONTINUE THE MINISTERIAL HAS YET  TO RESCHEDULE EVEN VIRTUALLY BUT  THE EU RED -- LED BY GERMANY'S  UK AND SWITZERLAND HAVE YET TO  ENDORSE SUPPORT FOR THE WAIVER  AND WE HAVE HEARD FROM FOREIGN  SOURCES THAT NEGOTIATIONS  CONTINUE AT THE MINISTERIAL  LEVEL ESPECIALLY AMONG THE U.S.  THE EU INDIA AND SOUTH AFRICA.  NO DETAILS ARE PUBLIC  INFORMATION IS AVAILABLE ON  PROGRESS OF THESE NEGOTIATORS  HOWEVER THERE ISSUES FOR THE  U.S. WHO ARE RELUCTANT TO  INCLUDE THERAPEUTICS AND  DIAGNOSTICS.  AS A MEDICAL ORGANIZATION WE  CONSIDERED ESSENTIAL TO ENSURE  ACCESS TO ALL TOOLS ESPECIALLY  WITH THE CURRENT SUPPLY SHORTAGE  OF THERAPEUTICS.  WHAT CAN YOU DO?  WE MEMBERS OF CONGRESS AND  CONGRESSIONAL STAFF TO APPLY  PRESSURE ON THE BIDEN  ADMINISTRATION TO LEAD IN  ADOPTION OF THE WAIVER FOR  VACCINES TREATMENTS AND TESTS.  FAMILY IS IMPAIRED OR THE U.S.  GOVERNMENT DEMAND PFIZER  BioNTECH AND MODERNA SHARE  THEIR TECHNOLOGY AND KNOW-HOW  WITH THE W. CHOSE TO TRANSFER IN  SOUTH AFRICA AND STANDS READY TO  MANUFACTURE MORE DOSES.  MODERNA WHO RECEIVED 10 BILLION  PUBLIC FUNDING HAS A PARTICULAR  RESPONSIBILITY IN THE COVID  VACCINE EFFORT.  AS OUTLINED TO THE SHARED  KNOWLEDGE WITH IDENTIFIED  MANUFACTURES IN THE GLOBAL  SOUTH.  THANKS LORI, BACK TO YOU.  >> RITA THANK YOU VERY MUCH AND  I WANT TO THANK ALL THE  SPEAKERS.  WE HAD SUCH A RICH CONVERSATION  AND WE HAVE GONE A LITTLE BIT  OVERTIME WITH EACH OF THE  PRESENTATIONS THAT IT'S COVERED  SO MUCH TERRITORY AND I'M SAD TO  SAY WE DON'T HAVE TIME FOR Q&A.  WE HAVE COVERED MOST OF THE  QUESTIONS I HAVE HEARD IN  ADVANCE FROM FOLKS WITH THEIR  AMAZING PANELS I WANT TO THANK  THE WHOLE PANOPLY OF  ORGANIZATIONS AND THE STUDY THAT  GARRETT HAS BEEN TALKING ABOUT  CAN BE FOUND ON THE PREP FOR ALL  WEB SITE OR THE RECORDING OF  THIS ENTIRE PRESENTATION WILL BE  FOUND AT AMERICAN LIBERTIES.US  AT WWW..  AMERICAN LIBERTIES.US ON THE  PROJECT WITH WORKSITE -- WEB  SITE IN THE HUMAN RIGHTS WATCH  WEB SITE IN DOCTORS WITHOUT  BORDERS WEB SITE IS STOCK FULL  OF IMPORTANT INFORMATION THAT  RITA SUMMARIZE FOR US THAT GOES  INTO ALL OF THE PROBLEMS IN THIS  REPORT IF YOU ARE CONGRESSIONAL  STAFFER AND YOU ARE NOT A  CO-SPONSOR WE HAVE A SMORGASBORD  OF ACTION ITEMS COVERED BY THIS  RESOLUTION.  PLEASE CONSIDER SPONSORING.  THE ONLY THING WE CAN'T DO IS  ACT AND I THINK EVERYONE FOR  THEIR PARTICIPATION AND I THINK  OUR AUDIENCE AND A BIT EVERYONE  FAREWELL.  THIS IS LORI WALLACH THE  DIRECTOR OF RETHINK TRADE.  THANK YOU ALL VERY, VERY MUCH."}]